Literature DB >> 9007471

Management of uncommon complications of definitive operations of Hirschsprung's disease.

A Sarioğlu1, M Senocak, A Hiçsönmez, N Büyükpamukçu.   

Abstract

In Hacettepe University Children's Hospital, 229 Hirschsprung patients who had undergone definitive operations of Hirschsprung's disease (HD) between 1976-1993 were evaluated for the occurrence of uncommon complications. Two hundred and thirteen of these patients were operated on in our hospital and 16 of them referred to us after definitive operation. The most uncommon complication in the presented series was the fistula; namely rectourinary, rectovaginal, ileorectal and perianal. One patient acquired rectourethral fistula after Swenson operation. He had undergone redo Swenson operation after an unsuccessful attempt of fistula repair. In our series we detected two patients with ileorectal fistula one of them has also a perianal fistula. These two patients were presented with intractable enterocolitis that caused a delay in treatment. Both of them had undergone ileorectal fistula repair with success. We encountered two rectovaginal fistulae among patients who were referred to us after definitive operations. Both of them were managed with redo operation. One patient was referred to us after Swenson operation with perianal fistula and had undergone fistulotomy. The management of rectourinary and rectovaginal fistulae other than redo operation was proved to be unsuccessful.

Entities:  

Mesh:

Year:  1996        PMID: 9007471     DOI: 10.1055/s-2008-1071015

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  2 in total

1.  Posterior sagittal approach in complicated Swenson's pull-through.

Authors:  O A Sowande; O Adejuyigbe
Journal:  J Indian Assoc Pediatr Surg       Date:  2008-01

2.  Experience with primary laparoscopy-assisted endorectal pull-through for Hirschsprung's disease.

Authors:  Nien-Lu Wang; Hung-Chang Lee; Ming-Lun Yeh; Pei-Yeh Chang; Jin-Cherng Sheu
Journal:  Pediatr Surg Int       Date:  2004-01-24       Impact factor: 1.827

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.